ABSTRACT
A semiempirical model, based in the logistic map, has been succesfully applied to forecast important quantities along the several phases of the outbreak of the covid-19 for different countries. This paper shows how the model was calibrated and applied to perform predictions of people needing to be hospitalized, needs of ventilators, or the number of deaths which would be produced. It is shown specifically the results obtained in the case of Spain, showing a prediction of diagnosed infected and deaths which will be observed after the ease of the total lockdown produced the 13th of March. Is also shown how this model can provide an insight of what the level of infection in the different regions of Spain is forecasted.
The model predicts for Spain for the end of May more than 400,000 diagnosed infected cases, number which will be probably higher due to the change in the possibilities of performing massive number of tests to the general population. The number of forecasted deaths for that date is 46,000± 15,000.
The model also predicts the level of infection at the different Spanish regions, providing a counterintuitive result in the cases of Madrid and Catalonia as the result shows a higher the level of infection at Catalonia than the level at Madrid, according with this model.
All of these results can be used to guide policy makers in order to optimize resources and to avoid future outbreaks of the covid-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this study
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used for the calculations and predictions contained within the paper are publicly available under demand